Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Kirilovsky

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Clémence Granier, Amos Kirilovsky, et al.
International Immunology|April 29, 2016
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patientsAmos Kirilovsky, Florence Marliot, Carine El Sissy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2024
Reply to Z. Gao et alCarine El Sissy, Amos Kirilovsky, Soledad Iseas, et al.
Frontiers in Immunology|January 9, 2019
Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS CriteriaElena Litvinova, Luc Darnige, Amos Kirilovsky, et al.
Cancers|April 3, 2021
Therapeutic Implications of the Immunoscore in Patients with Colorectal CancerCarine El Sissy, Amos Kirilovsky, Guy Zeitoun, et al.
Annales De Pathologie|February 6, 2017
[Focus on the Immunoscore and its potential clinical implications]Carine El Sissy, Florence Marliot, Nacilla Haicheur, et al.
AIDS (London, England)|May 9, 2014
Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllersAdèle de Masson, Amos Kirilovsky, Rima Zoorob, et al.
Bioinformatics (Oxford, England)|February 25, 2009
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksGabriela Bindea, Bernhard Mlecnik, Hubert Hackl, et al.
Cancer Research|February 10, 2011
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancerMarie Tosolini, Amos Kirilovsky, Bernhard Mlecnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reactionBernhard Mlecnik, Marie Tosolini, Amos Kirilovsky, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Clémence Granier, Amos Kirilovsky, et al.
International Immunology|April 29, 2016
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patientsAmos Kirilovsky, Florence Marliot, Carine El Sissy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2024
Reply to Z. Gao et alCarine El Sissy, Amos Kirilovsky, Soledad Iseas, et al.
Frontiers in Immunology|January 9, 2019
Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS CriteriaElena Litvinova, Luc Darnige, Amos Kirilovsky, et al.
Cancers|April 3, 2021
Therapeutic Implications of the Immunoscore in Patients with Colorectal CancerCarine El Sissy, Amos Kirilovsky, Guy Zeitoun, et al.
Annales De Pathologie|February 6, 2017
[Focus on the Immunoscore and its potential clinical implications]Carine El Sissy, Florence Marliot, Nacilla Haicheur, et al.
AIDS (London, England)|May 9, 2014
Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllersAdèle de Masson, Amos Kirilovsky, Rima Zoorob, et al.
Bioinformatics (Oxford, England)|February 25, 2009
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksGabriela Bindea, Bernhard Mlecnik, Hubert Hackl, et al.
Cancer Research|February 10, 2011
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancerMarie Tosolini, Amos Kirilovsky, Bernhard Mlecnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reactionBernhard Mlecnik, Marie Tosolini, Amos Kirilovsky, et al.
Pageof 4